Breaking News

Resilience to Build New Biopharma Manufacturing Facility in the UAE

The facility expands Resilience’s global footprint and represents the first GMP biopharma facility in the region based in the UAE.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, said that in conjunction with an equity investment in Resilience from Mubadala Investment Company PJSC, an Abu Dhabi sovereign investor, that the two parties have signed a deal intended to help secure the global biopharma supply chain and advance the United Arab Emirates’ (UAE) life sciences ecosystem through a biopharma manufacturing collaboration—which would r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters